InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.00%
)
US TECH 100
19,206.80
(
-0.04%
)
Dow Jones
39,127.80
(
0.00%
)
Brent Oil
85.09
(
0.73%
)
Bitcoin
61,206.07
(
0.65%
)
Post# of 252393
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119931
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 63383

Friday, 07/25/2008 4:08:06 AM

Friday, July 25, 2008 4:08:06 AM

Post# of 252393
LLY Formally Terminates Factor Xa Program

> LLY has not stated that it has discontinued development of LY517717…<

It’s now official. From yesterday’s CC:

http://seekingalpha.com/article/86916-eli-lilly-co-q2-2008-earnings-call-transcript?page=2

›“We’ve previously indicated that a toxicology finding had been observed in long-term animal studies with our Factor Xa Inhibitor. After completing a thorough review of the data, we have decided to halt clinical development of this compound.”‹

They still won’t say exactly what the tox problem was.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up